2024-09-11 - Analysis Report
## Lilly (LLY) Stock Analysis Report

**Company Overview:** Eli Lilly and Company is a leading pharmaceutical company specializing in the development and commercialization of innovative medicines.

**Performance Analysis:**

**1.  Performance vs. S&P 500:**

*   LLY's cumulative return stands at 532.57%, significantly exceeding the S&P 500's (VOO) return of 83.37%.
*   This translates to a staggering 449.2% outperformance, placing it at the 93.45% percentile within its historical range.

**2.  Recent Price Movement:**

*   Closing price: 908.27
*   5-day moving average: 925.31
*   20-day moving average: 934.46
*   60-day moving average: 894.42
*   The stock is currently trading below its 5 and 20-day moving averages, suggesting potential downward pressure in the short term. However, it sits above its 60-day average, indicating a longer-term bullish trend.

**3.  Technical Indicators:**

*   RSI: 45.06 –  A neutral reading, implying neither overbought nor oversold conditions.
*   PPO: -0.74 –  A negative value indicates potential downward momentum in price.
*   Delta_Previous_Relative_Divergence: 0.27 (negative) –  Suggests a short-term downward trend in the stock's relative performance.
*   Expected Return: 31.59% –  Represents the potential 5-year return on investment, assuming a continuous investment strategy.

**4.  Recent Earnings and Outlook:**

| Date       | EPS       | Revenue       |
| ---------- | ---------- | -------------- |
| 2024-08-08 | 3.29      | 11.30 B$      |
| 2024-04-30 | 2.49      | 8.77 B$       |
| 2023-11-02 | -0.06     | 9.50 B$       |
| 2023-08-08 | 1.96      | 8.31 B$       |
| 2024-08-08 | 1.96      | 8.31 B$       |

*   The latest earnings report for Q2 2024 exceeded analyst expectations, with EPS reaching 3.29. This indicates strong performance and potential for continued growth.
*   Revenue also showed a positive trend, reaching 11.30 Billion dollars.

**Overall Analysis:**

LLY's long-term performance has been remarkable, consistently outperforming the broader market. However, recent price movements suggest potential short-term weakness. While technical indicators offer mixed signals, the company's strong earnings performance and positive revenue growth suggest a bullish outlook. Despite the short-term volatility, LLY remains a compelling long-term investment opportunity with significant growth potential.

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. It is crucial to conduct your own research and consult with a financial professional before making any investment decisions.
